Cargando…

Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma

Antibody-dependent cellular phagocytosis- (ADCP-) related regulators (PRs) have been confirmed an important role in immunotherapy. However, the characterization of specific PRs in low-grade glioma (LGG) has not been comprehensively explored. In this study, we retrieved RNA-seq and CRISPR-Cas9 data t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianwen, Huang, Qianrong, Mo, Ligen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061072/ https://www.ncbi.nlm.nih.gov/pubmed/35510040 http://dx.doi.org/10.1155/2022/4142684

Ejemplares similares

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Screening and Identification of Key Biomarkers in Lower Grade Glioma via Bioinformatical Analysis
por: Guo, Fangzhou, et al.
Publicado: (2022)

Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy
por: Yang, Youyuan, et al.
Publicado: (2022)

Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas
por: Yan, Jun, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma
por: Deng, Teng, et al.
Publicado: (2021)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas
por: Tan, Shichuan, et al.
Publicado: (2022)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma
por: Li, Jin, et al.
Publicado: (2023)

Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Expression and prognostic characteristics of m(5)C regulators in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
por: Liu, Shiyu, et al.
Publicado: (2021)

Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas
por: Garcia, Catherine R., et al.
Publicado: (2018)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
por: Li, Jinna, et al.
Publicado: (2023)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma
por: Wang, Hua, et al.
Publicado: (2023)

Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma
por: Lu, Zhichao, et al.
Publicado: (2022)

Construction of a Risk Model to Predict the Prognosis and Immunotherapy of Low-Grade Glioma Ground on 7 Ferroptosis-Related Genes
por: Sun, Liwei, et al.
Publicado: (2022)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma
por: Su, Xiaotao, et al.
Publicado: (2021)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma
por: Luan, Yuxuan, et al.
Publicado: (2023)

Predicting regrowth of low-grade gliomas after radiotherapy
por: Plaszczynski, Stéphane, et al.
Publicado: (2023)

Prognostic value of magnetic resonance imaging features in low-grade gliomas
por: Deng, Liang, et al.
Publicado: (2019)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

An in silico approach to the identification of diagnostic and prognostic markers in low-grade gliomas
por: Özbek, Melih, et al.
Publicado: (2023)

Identification of an m6A RNA Methylation Regulator Risk Score Model for Prediction of Clinical Prognosis in Astrocytoma
por: Guo, Fangzhou, et al.
Publicado: (2022)

Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
por: Chen, Shaohua, et al.
Publicado: (2021)

Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
por: Zhou, Ying, et al.
Publicado: (2022)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
por: Tang, Guihua, et al.
Publicado: (2023)

Emerging phagocytosis checkpoints in cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients
por: Wang, Qi, et al.
Publicado: (2019)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma
por: Wang, Yuzhi, et al.
Publicado: (2022)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7h0kltddbjkuiroa0lq5ai1l46